Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. Delwail · SciRah

Researcher profile · Semantic Scholar

V. Delwail

Share profile

V. Delwail — researcher profile on SciRah

h-index: 37
Works: 144
Citations: 6,069

Most-cited papers

Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial.
L. Sehn, N. Chua, J. Mayer, G. Dueck +13 more
2016The Lancet Oncology322 citations
Semantic Scholar
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study.
C. Houillier, L. Taillandier, S. Dureau, T. Lamy +36 more
2019Journal of Clinical Oncology233 citations
Semantic Scholar
Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas
A. Gonzalez-Aguilar, A. Idbaih, B. Boisselier, Naïma Habbita +23 more
2012Clinical Cancer Research227 citations
Semantic Scholar
Management and outcome of primary CNS lymphoma in the modern era: An LOC network study.
C. Houillier, C. Soussain, H. Ghesquières, P. Soubeyran +54 more
2020Neurology197 citations Open access
Semantic Scholar
Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial.
A. Omuro, O. Chinot, L. Taillandier, H. Ghesquières +19 more
2015The Lancet Haematology173 citations
Semantic Scholar
R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma.
T. Lamy, G. Damaj, P. Soubeyran, E. Gyan +26 more
2018Blood167 citations Open access
Semantic Scholar
High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group
P. Colombat, A. Lemevel, P. Bertrand, V. Delwail +9 more
2006Bone Marrow Transplantation164 citations
Semantic Scholar
Upfront VIP‐reinforced‐ABVD (VIP‐rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS‐LTP95
A. Simon, M. Péoch, P. Casassus, E. Deconinck +16 more
2010British Journal of Haematology163 citations Open access
Semantic Scholar
High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years.
E. Gyan, C. Foussard, P. Bertrand, P. Michenet +17 more
2009Blood146 citations Open access
Semantic Scholar
Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study.
M. Czuczman, L. Fayad, V. Delwail, G. Cartron +16 more
2012Blood127 citations Open access
Semantic Scholar
Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study.
B. Cheson, N. Chua, J. Mayer, G. Dueck +13 more
2018Journal of Clinical Oncology122 citations Open access
Semantic Scholar
Impact of the use of autologous stem cell transplantation at first relapse both in naïve and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study
S. le Gouill, S. de Guibert, L. Planche, P. Brice +16 more
2011Haematologica109 citations Open access
Semantic Scholar
Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group.
F. Peyrade, S. Bologna, V. Delwail, J. Emile +16 more
2017The Lancet Haematology108 citations
Semantic Scholar
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study
C. Houillier, S. Dureau, L. Taillandier, R. Houot +28 more
2022Journal of Clinical Oncology89 citations
Semantic Scholar
Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma
E. Bachy, R. Houot, F. Morschhauser, A. Sonet +14 more
2013Haematologica84 citations Open access
Semantic Scholar
High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study
E. Schorb, C. Fox, K. Fritsch, L. Isbell +18 more
2017Bone Marrow Transplantation70 citations Open access
Semantic Scholar
Ibrutinib monotherapy in relapsed/refractory CNS lymphoma: A retrospective case series
K. Chamoun, S. Choquet, Eileen M. Boyle, C. Houillier +7 more
2017Neurology68 citations
Semantic Scholar
GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors.
J. Chiche, J. Reverso-Meinietti, A. Mouchotte, C. Rubio-Patiño +33 more
2019Cell Metabolism66 citations Open access
Semantic Scholar
Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial
W. Kim, Tae Min Kim, Seok-Goo Cho, I. Jarque +126 more
2025Nature Cancer60 citations Open access
Semantic Scholar
Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up.
P. Colombat, N. Brousse, G. Salles, F. Morschhauser +12 more
2012Annals of Oncology58 citations Open access
Semantic Scholar
First-line rituximab (R) high-dose therapy (R-HDT) versus R-CHOP14 for young adults with diffuse large B-cell lymphoma: Preliminary results of the GOELAMS 075 prospective multicenter randomized trial.
S. le Gouill, N. Milpied, T. Lamy, V. Delwail +14 more
2011Journal of Clinical Oncology46 citations
Semantic Scholar
A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma
R. Gressin, N. Daguindau, A. Tempescul, A. Moreau +36 more
2018Haematologica45 citations Open access
Semantic Scholar
First Results of the Acsé Pembrolizumab Phase II in the Primary CNS Lymphoma (PCNSL) Cohort
K. Hoang-Xuan, R. Houot, C. Soussain, M. Blonski +27 more
202041 citations Open access
Semantic Scholar
Evaluation of Ofatumumab, a Novel Human CD20 Monoclonal Antibody, as Single Agent Therapy in Rituximab-Refractory Follicular Lymphoma.
A. Hagenbeek, L. Fayad, V. Delwail, J. Rossi +14 more
200941 citations
Semantic Scholar
Update of the FL2000 randomized trial combining rituximab to CHVP-Interferon in follicular lymphoma (FL) patients (pts).
C. Foussard, N. Mounier, A. van Hoof, V. Delwail +7 more
2006Journal of Clinical Oncology38 citations
Semantic Scholar
Early versus late intensification for patients with high‐risk Hodgkin lymphoma—3 Cycles of intensive chemotherapy plus low‐dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell tran
N. Arakelyan, C. Berthou, B. Desablens, S. de Guibert +6 more
2008Cancer26 citations Open access
Semantic Scholar
Clinicopathological spectrum of renal parenchymal involvement in B-cell lymphoproliferative disorders.
V. Javaugue, C. Debiais-Delpech, M. Nouvier, E. Gand +15 more
2019Kidney International25 citations Open access
Semantic Scholar
Added Value of Spectroscopy to Perfusion MRI in the Differential Diagnostic Performance of Common Malignant Brain Tumors
Alexandre Vallée, Carole Guillevin, Michael Wager, V. Delwail +2 more
2018American Journal of Neuroradiology24 citations Open access
Semantic Scholar
Whole Brain Radiotherapy (WBRT) Versus Intensive Chemotherapy with Haematopoietic Stem Cell Rescue (IC + HCR) for Primary Central Nervous System Lymphoma (PCNSL) in Young Patients: An Intergroup Anocef-Goelams Randomized Phase II Trial (PRECIS)
C. Houillier, L. Taillandier, T. Lamy, O. Chinot +32 more
201624 citations
Semantic Scholar
Frontline Therapy with the Ribvd Regimen Elicits High Clinical and Molecular Response Rates and Long PFS in Elderly Patients Mantle Cell Lymphoma (MCL); Final Results of a Prospective Phase II Trial By the Lysa Group
R. Gressin, M. Callanan, N. Daguindau, A. Tempescul +34 more
201423 citations
Semantic Scholar
A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma: The GOELAMS LCP 99 trial
G. Olivier, A. Clavert, L. Lacotte-Thierry, M. Gardembas +9 more
2014American journal of hematology/oncology23 citations Open access
Semantic Scholar
GADOLIN: Primary results from a phase III study of obinutuzumab plus bendamustine compared with bendamustine alone in patients with rituximab-refractory indolent non-Hodgkin lymphoma.
L. Sehn, N. Chua, J. Mayer, G. Dueck +13 more
2015Journal of Clinical Oncology22 citations
Semantic Scholar
No Benefit of First-Line Rituximab (R) - High-Dose Therapy (R-HDT) Over R-CHOP14 for Young Adults with Diffuse Large B-Cell Lymphoma. Preliminary Results of the GOELAMS 075 Prospective Multicentre Randomized Trial
N. Milpied, S. Legouill, T. Lamy, V. Delwail +14 more
201021 citations
Semantic Scholar
Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product
D. Niederwieser, C. Hamm, P. Cobb, Mindy Mo +6 more
2020Targeted oncology19 citations Open access
Semantic Scholar
R-CHOP with or without Radiotherapy in Non-Bulky Limited-Stage Diffuse Large B Cell Lymphoma (DLBCL): Preliminary Results of the Prospective Randomized Phase III 02-03 Trial from the Lysa/Goelams Group
T. Lamy, G. Damaj, E. Gyan, P. Soubeyran +11 more
201419 citations
Semantic Scholar
Hodgkin lymphoma and female fertility: a multicenter study in women treated with doxorubicin, bleomycin, vinblastine, and dacarbazine
A. Machet, Caroline Poudou, C. Tomowiak, T. Gastinne +12 more
2022Blood Advances14 citations Open access
Semantic Scholar
Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies
Aurélie Cabannes-Hamy, F. Peyrade, F. Jardin, J. Emile +17 more
2018Cancer Medicine14 citations Open access
Semantic Scholar
Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas
N. Arakelyan, J. Jais, V. Delwail, J. Briére +6 more
2010Cancer13 citations Open access
Semantic Scholar
Long-term follow-up of tandem high-dose therapy with autologous stem cell support for adults with high-risk age-adjusted international prognostic index aggressive non-Hodgkin Lymphomas: a GOELAMS pilot study.
H. Monjanel, E. Deconinck, É. Perrodeau, T. Gastinne +6 more
2011Biology of Blood and Marrow Transplantation12 citations Open access
Semantic Scholar
Obinutuzumab versus Rituximab in transplant-eligible Mantle cell lymphoma patients.
C. Sarkozy, M. Callanan, C. Thieblemont, L. Obéric +18 more
2024Blood11 citations Open access
Semantic Scholar
CLINICAL ACTIVITY OF LONCASTUXIMAB TESIRINE PLUS IBRUTINIB IN NON‐HODGKIN LYMPHOMA: UPDATED LOTIS 3 PHASE 1 RESULTS
J. Depaus, N. Wagner-Johnston, P. Zinzani, T. Phillips +14 more
2021Hematological Oncology11 citations Open access
Semantic Scholar
Ibrutinib Is Effective in the Treatment of Autoimmune Haemolytic Anaemia in Mantle Cell Lymphoma
A. Galinier, V. Delwail, M. Puyade
2017Case Reports in Oncology11 citations Open access
Semantic Scholar
Multicenter randomized phase II trial of methotrexate (MTX) and temozolomide (TMZ) versus MTX, procarbazine, vincristine, and cytarabine for primary CNS lymphoma (PCNSL) in the elderly: An Anocef and Goelams Intergroup study.
A. Omuro, O. Chinot, L. Taillandier, H. Ghesquières +16 more
201311 citations
Semantic Scholar
Phase 2 Study Evaluating the Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Mantle Cell Lymphoma Previously Treated with Ibrutinib (CITADEL-205)
P. Zinzani, V. Delwail, S. Paneesha, S. Rule +10 more
2020Blood10 citations Open access
Semantic Scholar
Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study
P. Zinzani, M. Trněný, V. Ribrag, V. Zilioli +17 more
2023EClinicalMedicine9 citations Open access
Semantic Scholar
Patterns of use and safety of ibrutinib in real‐life practice
M. Allouchery, C. Tomowiak, S. Guidez, V. Delwail +4 more
2020British Journal of Clinical Pharmacology9 citations
Semantic Scholar
Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study
N. Younan, C. Soussain, S. Choquet, N. Cassoux +25 more
2022Hematological Oncology8 citations Open access
Semantic Scholar
[KHSV/EBV associated germinotropic lymphoproliferative disorder: a rare entity, case report and review of the literature].
M. Taris, A. de Mascarel, M. Riols, V. Delwail +3 more
2014Annales de Pathologie8 citations
Semantic Scholar
The Ribvd Regimen (Rituximab IV, Bendamustine IV, Velcade SC, Dexamethasone IV) Offers a High Complete Response Rate In Elderly Patients With Untreated Mantle Cell Lymphoma. Preliminary Results Of The Lysa Trial “Lymphome Du Manteau 2010 SA”
M. Callanan, N. Daguindau, A. Tempescul, S. Carras +34 more
20138 citations
Semantic Scholar
for the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
E. Bachy, R. Houot, F. Morschhauser, A. Sonet +17 more
20137 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Gressin×16
Invite
R. Gressin — researcher profile on SciRah
E. Gyan×16
Invite
E. Gyan — researcher profile on SciRah
C. Soussain×12
Invite
C. Soussain — researcher profile on SciRah
C. Houillier×11
Invite
C. Houillier — researcher profile on SciRah

×11

Invite

T. Lamy — researcher profile on SciRah

Invite

S. Choquet — researcher profile on SciRah

Invite

G. Damaj — researcher profile on SciRah

Invite

R. Houot — researcher profile on SciRah

S. le Gouill×11

Invite

S. le Gouill — researcher profile on SciRah

E. Deconinck×10

Invite

E. Deconinck — researcher profile on SciRah

Invite

G. Salles — researcher profile on SciRah

P. Soubeyran×9

Invite

P. Soubeyran — researcher profile on SciRah